Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Rheumatoid arthritis drugs approved

  • Comment

A number of new drugs for patients with rheumatoid arthritis have been recommended by NICE.

It has given the go-ahead for ituximab, adalimumab, etanercept, infliximab and abatacept to be considered as possible treatments for the condition after treatment with a tumour necrosis factor inhibitor has failed.

In separate guidance, NICE has also recommend that tocilizumab can be used with methotrexate in the treatment of patients who have not responded to, or cannot take, rituximab, or where a TMF inhibitor has failed.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs